JPS6140667B2 - - Google Patents
Info
- Publication number
- JPS6140667B2 JPS6140667B2 JP58129273A JP12927383A JPS6140667B2 JP S6140667 B2 JPS6140667 B2 JP S6140667B2 JP 58129273 A JP58129273 A JP 58129273A JP 12927383 A JP12927383 A JP 12927383A JP S6140667 B2 JPS6140667 B2 JP S6140667B2
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- formula
- compound
- hours
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Chemical group 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 150000002357 guanidines Chemical class 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- -1 ethoxythiocarbonylthio-2,3-diketobutane Chemical compound 0.000 description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- GCYDEHNKSNMNMN-UHFFFAOYSA-N (5-methyl-1h-imidazol-4-yl)methanethiol Chemical compound CC=1NC=NC=1CS GCYDEHNKSNMNMN-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- AQIXAKUUQRKLND-UHFFFAOYSA-N cimetidine Chemical compound N#C/N=C(/NC)NCCSCC=1N=CNC=1C AQIXAKUUQRKLND-UHFFFAOYSA-N 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- JCBJVAJGLKENNC-UHFFFAOYSA-M potassium ethyl xanthate Chemical compound [K+].CCOC([S-])=S JCBJVAJGLKENNC-UHFFFAOYSA-M 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- FNMHARGLJLWHAA-UHFFFAOYSA-N 1-(2-bromoethyl)-3-cyano-2-methylguanidine Chemical compound N#CNC(=NC)NCCBr FNMHARGLJLWHAA-UHFFFAOYSA-N 0.000 description 1
- RDENZTPLXCXCBQ-UHFFFAOYSA-N 1-(2-bromoethyl)-3-methylthiourea Chemical compound BrCCNC(=S)NC RDENZTPLXCXCBQ-UHFFFAOYSA-N 0.000 description 1
- HOJZUQSKSVMXON-UHFFFAOYSA-N 1-bromobutane-2,3-dione Chemical compound CC(=O)C(=O)CBr HOJZUQSKSVMXON-UHFFFAOYSA-N 0.000 description 1
- SIQWQBQGWREFSE-UHFFFAOYSA-N 1-cyano-2-methylguanidine Chemical compound CNC(N)=NC#N SIQWQBQGWREFSE-UHFFFAOYSA-N 0.000 description 1
- WJAXXWSZNSFVNG-UHFFFAOYSA-N 2-bromoethanamine;hydron;bromide Chemical compound [Br-].[NH3+]CCBr WJAXXWSZNSFVNG-UHFFFAOYSA-N 0.000 description 1
- PDWPOXKSTFGRIT-UHFFFAOYSA-N 4-(chloromethyl)-5-methyl-1h-imidazole;hydrochloride Chemical compound Cl.CC=1NC=NC=1CCl PDWPOXKSTFGRIT-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- XMYLSWOTJKUSHE-UHFFFAOYSA-N cyanamide;lead Chemical compound [Pb].NC#N XMYLSWOTJKUSHE-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- XCAUINMIESBTBL-UHFFFAOYSA-N lead(ii) sulfide Chemical compound [Pb]=S XCAUINMIESBTBL-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- NRTLTGGGUQIRRT-UHFFFAOYSA-N triethylazanium;bromide Chemical compound [Br-].CC[NH+](CC)CC NRTLTGGGUQIRRT-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C329/00—Thiocarbonic acids; Halides, esters or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/16—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
- C07D203/20—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carbonic acid, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60291815A JPS61171471A (ja) | 1977-12-28 | 1985-12-23 | ダアニジン誘導体の製造方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1612677A CH626353A5 (en) | 1977-12-28 | 1977-12-28 | Process for the preparation of a guanidine |
CH16126/77 | 1977-12-28 | ||
CH12477/78 | 1978-12-07 | ||
CH1247778A CH636348A5 (en) | 1978-12-07 | 1978-12-07 | Process for the preparation of guanidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5962572A JPS5962572A (ja) | 1984-04-10 |
JPS6140667B2 true JPS6140667B2 (pl) | 1986-09-10 |
Family
ID=25710349
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53164401A Expired JPS5827792B2 (ja) | 1977-12-28 | 1978-12-28 | 4−メチル−5−メルカプトメチルイミダゾ−ル |
JP58129273A Granted JPS5962572A (ja) | 1977-12-28 | 1983-07-14 | グアニジン誘導体の製造方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53164401A Expired JPS5827792B2 (ja) | 1977-12-28 | 1978-12-28 | 4−メチル−5−メルカプトメチルイミダゾ−ル |
Country Status (12)
Country | Link |
---|---|
JP (2) | JPS5827792B2 (pl) |
CS (1) | CS208770B2 (pl) |
DE (1) | DE2855836A1 (pl) |
ES (1) | ES476707A1 (pl) |
FI (1) | FI74954C (pl) |
IL (1) | IL56265A (pl) |
IT (1) | IT1102776B (pl) |
NL (1) | NL184832C (pl) |
PL (1) | PL115042B1 (pl) |
RO (1) | RO76087A (pl) |
SU (1) | SU1077570A3 (pl) |
YU (1) | YU41138B (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL56265A (en) * | 1977-12-28 | 1982-08-31 | Om Lab Sa | Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor |
GR65283B (en) * | 1977-12-30 | 1980-08-01 | Crc Ricerca Chim | Method for the alkyliosis of 4(5)-merka ptomethyl-imidazoles with aziridin derivatives |
YU40332B (en) * | 1978-04-26 | 1985-12-31 | Lek Tovarna Farmacevtskih | Process for preparing n-cyano-n'-methyl-n''-((2-((4-methyl-5-imidazolyl)-methylthio)ethyl)-guanidine |
LU81178A1 (de) * | 1978-05-12 | 1979-09-10 | Crc Ricerca Chim | Neue thiolderivate des imidazols |
US4222845A (en) * | 1978-12-13 | 1980-09-16 | Gulf Oil Corporation | Integrated coal liquefaction-gasification-naphtha reforming process |
WO1980001694A1 (en) * | 1979-02-14 | 1980-08-21 | Rech Syntheses Organ | Imino-alkyl and amino-nitryl cyano-guanidinze |
CH642068A5 (fr) * | 1979-03-14 | 1984-03-30 | Rech Syntheses Organ | Cyano-urees et cyano-thiourees therapeutiquement actives. |
PT72320B (en) | 1980-01-08 | 1982-07-23 | Glaxo Group Ltd | Process for preparation of a furan derivative |
YU41689B (en) * | 1980-01-14 | 1987-12-31 | Lek Tovarna Farmacevtskih | Process for preparing imidazole derivatives |
DE3014353A1 (de) * | 1980-04-15 | 1982-01-21 | Bayer Ag, 5090 Leverkusen | Trisubstituierte cyanguanidine, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
JPS5888366A (ja) * | 1981-11-19 | 1983-05-26 | Fujimoto Seiyaku Kk | グアニジン誘導体の製造法 |
JPS59130273A (ja) * | 1983-01-14 | 1984-07-26 | Tokawa Tetsuo | イミダゾ−ル系化合物の製造法 |
JPS6170789U (pl) * | 1984-10-16 | 1986-05-14 | ||
GB8502446D0 (en) * | 1985-01-31 | 1985-03-06 | Smith Kline French Lab | Preparing aziridine derivative |
SI8710091A8 (en) * | 1987-01-23 | 1996-06-30 | Lek Tovarna Farmacevtskih | Process for obtaining crystalline cimetadine (n-cyano-n'-methyl-n"- (2/(5-methyl-1h-imidazole-4-yl)methylthio/ethyl)-guanidine |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51125074A (en) * | 1974-09-02 | 1976-11-01 | Smith Kline French Lab | Production of heterocyclic compound |
JPS5440547A (en) * | 1977-09-07 | 1979-03-30 | Seikosha Kk | Device for adjusting output frequency of frequency divider |
JPS54130566A (en) * | 1977-12-28 | 1979-10-09 | Om Lab Sa | Manufacture of guanidine derivative |
JPS5827792A (ja) * | 1981-08-10 | 1983-02-18 | Ikeda Hiromi | ガソリンエンジン用液体燃料 |
JPS5888366A (ja) * | 1981-11-19 | 1983-05-26 | Fujimoto Seiyaku Kk | グアニジン誘導体の製造法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE36050B1 (en) * | 1971-03-09 | 1976-08-04 | Smith Kline French Lab | Ureas thioureas and guanidines |
GB1531231A (en) * | 1974-09-02 | 1978-11-08 | Smith Kline French Lab | Process for the production of cyanoguanidine derivatives |
JPS5817511B2 (ja) * | 1975-10-03 | 1983-04-07 | 積水化学工業株式会社 | セツチヤクザイソセイブツ |
MW5076A1 (en) * | 1975-12-29 | 1978-02-08 | Smith Kline French Lab | Pharmacologicalle active compounds |
JPS5742068A (en) * | 1980-08-27 | 1982-03-09 | Ricoh Co Ltd | Solvent recovering device for wet type electronic copying machine |
-
1978
- 1978-12-20 IL IL7856265A patent/IL56265A/xx unknown
- 1978-12-22 DE DE19782855836 patent/DE2855836A1/de active Granted
- 1978-12-22 ES ES476707A patent/ES476707A1/es not_active Expired
- 1978-12-27 YU YU3084/78A patent/YU41138B/xx unknown
- 1978-12-27 CS CS788968A patent/CS208770B2/cs unknown
- 1978-12-27 FI FI783990A patent/FI74954C/fi not_active IP Right Cessation
- 1978-12-28 SU SU782704652A patent/SU1077570A3/ru active
- 1978-12-28 PL PL1978212223A patent/PL115042B1/pl unknown
- 1978-12-28 RO RO7896094A patent/RO76087A/ro unknown
- 1978-12-28 NL NLAANVRAGE7812600,A patent/NL184832C/xx not_active IP Right Cessation
- 1978-12-28 IT IT7831392A patent/IT1102776B/it active
- 1978-12-28 JP JP53164401A patent/JPS5827792B2/ja not_active Expired
-
1983
- 1983-07-14 JP JP58129273A patent/JPS5962572A/ja active Granted
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51125074A (en) * | 1974-09-02 | 1976-11-01 | Smith Kline French Lab | Production of heterocyclic compound |
JPS5440547A (en) * | 1977-09-07 | 1979-03-30 | Seikosha Kk | Device for adjusting output frequency of frequency divider |
JPS54130566A (en) * | 1977-12-28 | 1979-10-09 | Om Lab Sa | Manufacture of guanidine derivative |
JPS5962572A (ja) * | 1977-12-28 | 1984-04-10 | スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド | グアニジン誘導体の製造方法 |
JPS5827792A (ja) * | 1981-08-10 | 1983-02-18 | Ikeda Hiromi | ガソリンエンジン用液体燃料 |
JPS5888366A (ja) * | 1981-11-19 | 1983-05-26 | Fujimoto Seiyaku Kk | グアニジン誘導体の製造法 |
Also Published As
Publication number | Publication date |
---|---|
IL56265A (en) | 1982-08-31 |
FI783990A (fi) | 1979-06-29 |
DE2855836A1 (de) | 1979-07-12 |
DE2855836C2 (pl) | 1989-09-28 |
RO76087A (ro) | 1981-02-28 |
CS208770B2 (en) | 1981-09-15 |
NL7812600A (nl) | 1979-07-02 |
JPS5962572A (ja) | 1984-04-10 |
IL56265A0 (en) | 1979-03-12 |
JPS54130566A (en) | 1979-10-09 |
YU41138B (en) | 1986-12-31 |
FI74954C (fi) | 1988-04-11 |
SU1077570A3 (ru) | 1984-02-29 |
IT7831392A0 (it) | 1978-12-28 |
PL115042B1 (en) | 1981-03-31 |
NL184832C (nl) | 1989-11-16 |
YU308478A (en) | 1983-01-21 |
ES476707A1 (es) | 1979-06-01 |
PL212223A1 (pl) | 1979-08-27 |
FI74954B (fi) | 1987-12-31 |
IT1102776B (it) | 1985-10-07 |
JPS5827792B2 (ja) | 1983-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6140667B2 (pl) | ||
US4013678A (en) | Process for preparing heterocyclicalkylthioalkyl-n-cyanoguanidines | |
CA1190224A (en) | Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists | |
TWI662032B (zh) | 製備噻蟲嗪的方法 | |
US10934269B2 (en) | Process for preparation of apalutamide | |
JPS639512B2 (pl) | ||
NO172118B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt n-(omega-substituert -alkyl)-n'-((imidazol-4-yl)alkyl)-guanidin | |
DE2604056A1 (de) | Thiocarbaminsaeure-derivate | |
JPS649318B2 (pl) | ||
JPS6030310B2 (ja) | イミダゾールの製法 | |
EP0269650A1 (en) | Synthesis of antiulcer compounds | |
JP3081359B2 (ja) | 2−アミノ−1−フェニル−1−エタノール誘導体 | |
CA3144551A1 (en) | Large scale process of 3,3'-dideoxy-3,3'-bis-[4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl]-1,1'-sulfanediyl-di-beta-d-galactopyranoside | |
JPS63201165A (ja) | シアノグアニジン誘導体及びその製造法 | |
US4090026A (en) | Certain nitrogen heterocyclic isothiocyanate esters | |
JPH0113469B2 (pl) | ||
JPS62155268A (ja) | ナイザチジンの合成法 | |
EP0178123A2 (en) | 2-Guanidino-4-(2-methyl-4-imidazolyl)thiazole dihydrobromide and process therefor | |
JPS6156224B2 (pl) | ||
JPS636063B2 (pl) | ||
JPS5859972A (ja) | グアニジン誘導体の製造方法 | |
JPH0586943B2 (pl) | ||
CA1227492A (en) | Process for the preparation of a compound having anti- ulcer activity | |
JPH0623180B2 (ja) | シアノグアニジン誘導体及びその製造法 | |
RU2042671C1 (ru) | Производное дикетен-имина в качестве промежуточного продукта для синтеза ранитидина и способ его получения |